Functional effects of SNAP-25 carboxyl terminal peptide on excitatory synaptic transmission in rat superior cervical ganglion neurons in culture

University of York (2002) J Physiol 539P, S043

Communications: Functional effects of SNAP-25 carboxyl terminal peptide on excitatory synaptic transmission in rat superior cervical ganglion neurons in culture

G.J. Stephens* and S. Mochida†

*Neuronal Excitability Group, Biological Sciences, Imperial College, London SW7 2BZ, UK and †Department of Physiology, Tokyo Medical University, Tokyo 160-8402, Japan

View other abstracts by:


The 25 kDa synaptosome-associated protein (SNAP-25) is a key component of the plasma membrane soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) which regulates neurotransmitter release at presynaptic terminals. Resolution of the crystal structure of a SNARE complex has shown that SNAP-25 interacts with syntaxin primarily via an amino terminal site and VAMP/synaptobrevin via a carboxyl terminal site (Sutton et al. 1998). Truncation of the SNAP-25 carboxyl terminal (SNAP-25-CT) inhibits SNAP-25 binding to VAMP in vitro (Chapman et al. 1994). SNAP-25 also binds to the subtypes of voltage-dependent Ca2+ channels implicated in presynaptic neuro-transmitter release (Sheng et al. 1996).

To investigate the physiological consequences of SNAP-25-CT on the disassembly of preformed SNARE complexes, we examined the role of SNAP-25-CT in synaptic transmission at cholinergic synapses formed between rat superior cervical ganglion neurons (SCGNs) in culture. SCGNs were prepared from 7-day-old rats using standard, humane, procedures. Following a stable period of recording evoked excitatory postsynaptic potentials (EPSPs), a synthetic peptide of the carboxyl terminal 13 amino acids of SNAP-25 (aa 194-206) was diffused (at t = 0 for 2-3 min) into the presynaptic neuron from a suction pipette containing a 1:1 solution of 2.5 mM peptide and 5 % Fast Green FCF.

EPSP amplitude gradually decreased after peptide injection. At a stimulation frequency of 0.05 Hz, the maximum EPSP decrease was observed at 40-50 min; the reduction in EPSPs was 20 ± 12 % (mean ± S.E.M.) 50 min after injection (P ≤ 0.05, Student’s t test). No obvious change in the time course of the EPSPs was observed with SNAP-25 peptide injection. A control peptide containing 26 amino acids of SNAP-25 (aa 146-171), which does not interact with presynaptic SNAREs, showed no significant effect on synaptic transmission (0.05 Hz, n = 4). We next examined the effects of stimulation frequency. The maximum EPSP decrease was observed at 40-50 min for frequencies of 0.1 and 0.2 Hz; the reduction in EPSPs was 24 ± 6.4 % (0.1 Hz, at 40 min, n = 6) and 31 ± 9.3 % (0.2 Hz, at 50 min, n = 5).

Although these data show a correlation between frequency and inhibition of mean EPSPs, a similar trend was seen in control conditions, consistent with the SNAP-25 effect not being dependent on synaptic activity. However, it is clear that the SNAP-25-CT peptide inhibits excitatory synaptic transmission in SCGNs, possibly by acting as a competitor with SNAP-25 for SNARE complex assembly, implicating the SNAP-25 C terminal as an important molecular determinant of SNARE function.

This work was supported by The Wellcome Trust and The Japanese Ministry of Education, Science, Sports and Culture.




Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type